Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Depression in the Elderly
1
x
$
30.00
VOL 3 No. 11 Full Issue - November 2001
1
x
$
20.00
The Impact of Completing Medication Reconciliation and Depression Treatment History in an Outpatient Depression Clinic
1
x
$
30.00
The Effectiveness of Long-Acting Injectable Risperidone in a Population of Psychiatric Out-Patients: 1-Year Naturalistic Study
1
x
$
30.00
Quetiapine and Paediatric Psychiatrica: Evidence or Diffidence?
1
x
$
30.00
Impact of Pharmacophobia and Pharmacophilia on Perception of Medication Use and Self-Medication Behaviors in Saudi Arabia
1
x
$
30.00
Vanderbilt ADHD Diagnostic Teacher Rating Scale
1
x
$
0.00
Psychopharmacology Bulletin VOL 47 No. 4, 2017 - Full Issue Stacked PDF
1
x
$
60.00
Obesogenic Medications and Weight Gain Over 24 Weeks in Patients with Depression: Results from the GUIDED Study
1
x
$
30.00
Psychopharmacotherapy of Premenstrual Dysphoric Disorder—New Vistas
1
x
$
30.00
A Case of Olanzapine-Induced Fever
1
x
$
30.00
Incretin Mimetics (GLP-1 Agonists) as an Addition to the Psychopharmacology Armamentarium
1
x
$
30.00
Efficacy of Rivastigmine Augmentation on Positive and Negative Symptoms, General Psychopathology, and Quality of Life in Patients with Chronic Schizophrenia: A Randomized Controlled Trial
1
x
$
30.00
Serotonin and Norepinephrine Reuptake Inhibitors (SNRIs) for Treatment of Fibromyalgia: A Comprehensive Clinical Review
1
x
$
30.00
Predictors of Non-Stabilization during the Combination Therapy of Lithium and Divalproex in Rapid Cycling Bipolar Disorder: A Post-hoc Analysis of Two Studies
1
x
$
30.00
Opciones fármacoterapéuticas en el tratamiento de la depresión y ansiedad comórbidas
1
x
$
0.00
View Cart
Checkout
Home
Store
“Opciones fármacoterapéuticas en el tratamiento de la depresión y ansiedad comórbidas” has been added to your cart.
View cart
Sort by
Name
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Letter From the Editors: Are We Prepared for the Genomics Era?
$
0.00
Add to cart
Details
Letter From the Editors: Are You Ready For Some Ethics, Some Success, Some Cytoprotectants, and Some New Board Members?
$
0.00
Add to cart
Details
Letter From the Editors: Lymphomas – The Diseases That Taught Us Monoclonal Antibodies Can Work
$
0.00
Add to cart
Details
Letter From the Editors: Right Tool, Right Time, Right Reason
$
0.00
Add to cart
Details
Letter to the Editor: AGGRAVATION OF SCHIZOPHRENIA BY CLOMIPRAMINE IN A PATIENT WITH COMORBID OBSESSIVE-COMPULSIVE DISORDER
$
0.00
Add to cart
Details
LETTER TO THE EDITOR: GLUCOSE TESTING IN PATIENTS RECEIVING ANTIPSYCHOTIC PHARMACOTHERAPY
$
0.00
Add to cart
Details
Lidocaine Ineffectiveness Suggests New Psychopharmacology Drug Target
$
30.00
Add to cart
Details
Lieuwe de Haan, MD, PhD: Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
$
30.00
Add to cart
Details
Lineamientos universales: Indíce de medicamentos para Latinoamérica
$
0.00
Add to cart
Details
Lithium-Induced Hyperparathyroidism: An Ill-defined Territory (OPEN ACCESS)
$
0.00
Add to cart
Details
Long Acting Injectables and their Correlation with Subjectivity in Schizophrenia Spectrum Disorder
$
30.00
Add to cart
Details
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Long-Acting Injectable Paliperidone Palmitate: A Review of Efficacy and Safety
$
30.00
Add to cart
Details
Long-Term Antidepressant Treatment
$
30.00
Add to cart
Details
Long-Term Outcomes of Post Dural Puncture Headache Treated With Epidural Blood Patch: A Pilot Study
$
30.00
Add to cart
Details
Long-Term Safety and Tolerability of Valbenazine (NBI-98854) in Subjects with Tardive Dyskinesia and a Diagnosis of Schizophrenia or Mood Disorder
$
0.00
Add to cart
Details
Long-Term Treatment Strategies in Affective Disorders
$
30.00
Add to cart
Details
Long-Term Treatment Strategies in Anxiety Disorders
$
30.00
Add to cart
Details
Lori Davis, MD: Clinical and Pharmacoeconomic Evaluation of Switch to Olanzapine in Veterans with Schizophrenia or Schizoaffective Disorder
$
30.00
Add to cart
Details
Low-Dose Risperidone for an Autistic Child with Comorbid ARFID and Misophonia
$
30.00
Add to cart
Details
Previous
1
…
21
22
23
…
44
Next
Page load link
Go to Top
